122 related articles for article (PubMed ID: 26473355)
1. The Genotype of the Donor for the (GT)n Polymorphism in the Promoter/Enhancer of FOXP3 Is Associated with the Development of Severe Acute GVHD but Does Not Affect the GVL Effect after Myeloablative HLA-Identical Allogeneic Stem Cell Transplantation.
Noriega V; Martínez-Laperche C; Buces E; Pion M; Sánchez-Hernández N; Martín-Antonio B; Guillem V; Bosch-Vizcaya A; Bento L; González-Rivera M; Balsalobre P; Kwon M; Serrano D; Gayoso J; de la Cámara R; Brunet S; Rojas-Contreras R; Nieto JB; Martínez C; Gónzalez M; Espigado I; Vallejo JC; Sampol A; Jiménez-Velasco A; Urbano-Ispizua A; Solano C; Gallardo D; Díez-Martín JL; Buño I;
PLoS One; 2015; 10(10):e0140454. PubMed ID: 26473355
[TBL] [Abstract][Full Text] [Related]
2. [Difference between FOXP3 gene expressions in donor grafts with or without acute graft-versus-host disease].
Wang ZD; Feng SZ; Zhou SY; Wang M; Zhou Z; Zhai WJ; Han MZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1215-20. PubMed ID: 17204197
[TBL] [Abstract][Full Text] [Related]
3. Effect of FOXP3 polymorphism on the clinical outcomes after allogeneic hematopoietic stem cell transplantation in pediatric acute leukemia patients.
Piao Z; Kim HJ; Choi JY; Hong CR; Lee JW; Kang HJ; Park KD; Shin HY
Int Immunopharmacol; 2016 Feb; 31():132-9. PubMed ID: 26735609
[TBL] [Abstract][Full Text] [Related]
4. Association of FOXP3 Single Nucleotide Polymorphisms With Clinical Outcomes After Allogenic Hematopoietic Stem Cell Transplantation.
Nam M; Shin S; Park KU; Kim I; Yoon SS; Kwon TK; Song EY
Ann Lab Med; 2018 Nov; 38(6):591-598. PubMed ID: 30027704
[TBL] [Abstract][Full Text] [Related]
5. Association of recipient and donor interleukin 6 polymorphisms 174 and 597 with outcome after allogeneic hematopoietic stem cell transplantation in children.
Wetzel L; Wittig S; Gruhn B
J Cancer Res Clin Oncol; 2022 Jan; 148(1):255-265. PubMed ID: 34120222
[TBL] [Abstract][Full Text] [Related]
6. Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants.
Middleton PG; Taylor PR; Jackson G; Proctor SJ; Dickinson AM
Blood; 1998 Nov; 92(10):3943-8. PubMed ID: 9808588
[TBL] [Abstract][Full Text] [Related]
7. Influence of FOXP3 single-nucleotide polymorphism after allogeneic hematopoietic stem cell transplantation.
Kuroiwa K; Sato M; Narita H; Okamura R; Uesugi Y; Sasaki Y; Shimada S; Watanuki M; Fujiwara S; Kawaguchi Y; Arai N; Yanagisawa K; Iezumi K; Hattori N
Int J Hematol; 2024 May; 119(5):583-591. PubMed ID: 38418747
[TBL] [Abstract][Full Text] [Related]
8. Donor-Derived Myeloid Heme Oxygenase-1 Controls the Development of Graft-Versus-Host Disease.
Spilleboudt C; De Wilde V; Lewalle P; Cabanne L; Leclerc M; Beckerich F; Bories D; Cardoso S; Soares MP; Vokaer B; Hougardy JM; Flamand V; Racapé J; Abramowicz M; Maury S; Le Moine A
Front Immunol; 2020; 11():579151. PubMed ID: 33537027
[TBL] [Abstract][Full Text] [Related]
9. High preharvest donor Foxp3 mRNA level predicts late relapse of acute lymphoblastic leukaemia after haematopoietic stem cell transplantation.
Jacobsen N; Frisch T; Keiding N; Heilmann C; Sengeløv H; Madsen HO; Marquart H; Dickmeiss E; Andersen MK; Christiansen CB; Ryder LP
Eur J Haematol; 2021 May; 106(5):643-653. PubMed ID: 33527553
[TBL] [Abstract][Full Text] [Related]
10. Recipient and donor JAK2 46/1 haplotypes are associated with acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Balassa K; Krahling T; Remenyi P; Batai A; Bors A; Kiss KP; Torbagyi E; Gopcsa L; Lengyel L; Barta A; Varga G; Tordai A; Masszi T; Andrikovics H
Leuk Lymphoma; 2017 Feb; 58(2):391-398. PubMed ID: 27389386
[TBL] [Abstract][Full Text] [Related]
11. Association of cytotoxic T-lymphocyte antigen-4 (CTLA-4) single nucleotide polymorphism in donors with clinical outcome after allogeneic hematopoietic stem cell transplantation: a meta-analysis.
Wang Z; Zhang Y; Du Y; Song F; Gao S
Hematology; 2021 Dec; 26(1):144-152. PubMed ID: 33491603
[TBL] [Abstract][Full Text] [Related]
12. High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT.
Rezvani K; Mielke S; Ahmadzadeh M; Kilical Y; Savani BN; Zeilah J; Keyvanfar K; Montero A; Hensel N; Kurlander R; Barrett AJ
Blood; 2006 Aug; 108(4):1291-7. PubMed ID: 16627754
[TBL] [Abstract][Full Text] [Related]
13. LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors.
Cruz D; Rodríguez-Romanos R; González-Bartulos M; García-Cadenas I; de la Cámara R; Heras I; Buño I; Santos N; Lloveras N; Velarde P; Tuset E; Martínez C; González M; Sanz GF; Ferrá C; Sampol A; Coll R; Pérez-Simón JA; López-Jiménez J; Jurado M; Gallardo D
Front Immunol; 2023; 14():1066393. PubMed ID: 36742309
[TBL] [Abstract][Full Text] [Related]
14. Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype.
Sugimoto K; Murata M; Onizuka M; Inamoto Y; Terakura S; Kuwatsuka Y; Oba T; Miyamura K; Kodera Y; Naoe T
Int J Hematol; 2008 Jun; 87(5):451-458. PubMed ID: 18365141
[TBL] [Abstract][Full Text] [Related]
15. Association between interleukin-10 promoter gene polymorphisms and acute graft-versus-host disease after hematopoietic stem cell transplantation: a systematic review and meta-analysis.
Cho IH; Song YK; Kim MG; Han N; Kim T; Oh JM
Hematology; 2015 Apr; 20(3):121-8. PubMed ID: 25116082
[TBL] [Abstract][Full Text] [Related]
16. Donor Genetic Predisposition to High Interleukin-10 Production Appears Protective against Acute Graft-Versus-Host Disease.
Tripathi G; Khanolkar RA; Faridi RM; Kalra A; Dharmani-Khan P; Shabani-Rad MT; Berka N; Daly A; Storek J; Khan FM
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555525
[TBL] [Abstract][Full Text] [Related]
17. IL10 and IL10 receptor gene variation and outcomes after unrelated and related hematopoietic cell transplantation.
Tseng LH; Storer B; Petersdorf E; Lin MT; Chien JW; Grogan BM; Malkki M; Chen PJ; Zhao LP; Martin PJ; Hansen JA
Transplantation; 2009 Mar; 87(5):704-10. PubMed ID: 19295315
[TBL] [Abstract][Full Text] [Related]
18. Non-HLA immunogenetic polymorphisms and the risk of complications after allogeneic hemopoietic stem-cell transplantation.
Mullighan C; Heatley S; Doherty K; Szabo F; Grigg A; Hughes T; Schwarer A; Szer J; Tait B; To B; Bardy P
Transplantation; 2004 Feb; 77(4):587-96. PubMed ID: 15084940
[TBL] [Abstract][Full Text] [Related]
19. A molecular and computational diagnostic approach identifies FOXP3, ICOS, CD52 and CASP1 as the most informative biomarkers in acute graft-versus-host disease.
Cuzzola M; Fiasché M; Iacopino P; Messina G; Martino M; Console G; Fedele R; Massi D; Recchia AG; Irrera G; Morabito F
Haematologica; 2012 Oct; 97(10):1532-8. PubMed ID: 22491736
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of single nucleotide polymorphisms in the interleukin-6 receptor and their effects on pre- and post-transplant serum mediator level and outcome after allogeneic stem cell transplantation.
Tvedt THA; Hovland R; Tsykunova G; Ahmed AB; Gedde-Dahl T; Bruserud Ø
Clin Exp Immunol; 2018 Jul; 193(1):130-141. PubMed ID: 29513361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
